Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite
Get Alerts TECH Hot Sheet
Join SI Premium – FREE
- New SPYRE™ Focus Panels (Stroma and Vessel) broaden modular panel options, enabling deeper targeted insights in spatial biology workflows.
- SPYRE™ Amplification Kits leverage sequential and enhanced layered amplification (seqLA™) technology enabling improved detection of low-abundance and challenging targets.
- Enhancements strengthen the fully integrated COMET spatial biology ecosystem, supporting increased consumables adoption and panel expansion.
"Researchers need tools that make it easier to extract meaningful answers from complex tissue samples," said
SPYRE™ Antibody Panels, including the newly introduced Stroma and Vessel Focused Panels, are modular antibody panels designed to enable flexible multiplex assay design while reducing optimization time. Panels leverage validated antibodies with ready-to-use protocols to streamline setup while maintaining flexibility to incorporate markers from a lab's own antibody library. SPYRE™ Amplification Kits use seqLA™ technology to improve the detection of low‑abundance and difficult‑to‑detect targets.
"Utilizing the pre-optimized SPYRE panel has not only increased the capacity of conventional multiplex immunofluorescence but also enabled a one-day experimental protocol," said Prof.
Together, SPYRE Focus Panels and SPYRE Amplification Kits strengthen Bio-Techne's commitment to deliver a fully integrated, modular, and automated spatial biology ecosystem that accelerates research and preclinical therapeutic development. These innovations continue to empower researchers to generate richer data and deeper biological understanding from every tissue sample.
ABOUT BIO-TECHNE:
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and has approximately 3,100 employees worldwide. For more information, visit www.bio-techne.com or follow the Company on social media at LinkedIn, X and YouTube.
MEDIA CONTACTS:
Corporate Communications
[email protected]
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-advances-spatial-biology-with-modular-expansion-of-comet-suite-302724287.html
SOURCE Bio-Techne Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OPENLANE Announces Pricing of Secondary Offering of Common Stock, Including Concurrent Share Repurchase
- Croud Consumer Index Reveals 69% Of Americans Would Let AI Buy For Them Without Approval
- Optimal Transit Unveils Second Configuration of the Kraaken™ Data Center: A Ship That Can Power 32,000 Homes, Produce Clean Water for 150,000 People, and Host 60 MW of AI Compute – With No Fuel an
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share